© Sanologics Inc. 2023
Menu
Sanologics
Sano – Latin for heal, cure, make healthy, repair
+
Biologics – A substance that is made from a living organism or its products and is used in the prevention, diagnosis, or treatment of cancer and other diseases
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706466/
Rice JB, et al. Diabetes Care. 2014; 37: 651-8.
Diabetic foot ulcers (DFUs) (30.5%), for example, have a comparable 5-year mortality rate to cancer (31%)… (4)
The most common wounds are driven by metabolic disruptions (e.g., diabetes), vascular deficits (e.g., venous or arterial insufficiency), or mechanical impacts (e.g., persistent/ localized pressure)
In the United States, 3% of the population older than 65 years have open wounds. By the year 2060, the U.S. government estimates that the elderly population will be over 77 million, (12)
Traditional wound care isn’t working. Chronic non-healing wounds (CNHW) are quickly becoming known as the “silent epidemic” with suffering individuals surpassing 6.5 million with financial impact staggering into the Billions.
Now is the time to move from traditional wound care treatments to modern wound care solutions!
Medicare cost projections for all wounds ranged from $28.1 to $96.8 billion, including costs for infection management, among which surgical wounds and diabetic ulcers were the most expensive to treat.1
Diabetic foot ulcers (DFUs) (30.5%), for example, have a comparable 5-year mortality rate to cancer (31%)…4
The most common wounds are driven by metabolic disruptions (e.g., diabetes), vascular deficits (e.g., venous or arterial insufficiency), or mechanical impacts (e.g., persistent/localized pressure)
In the United States, 3% of the population older than 65 years have open wounds. By the year 2060, the U.S. government estimates that the elderly population will be over 77 million,12
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024242/
Modern wound care requires modern solutions utilizing the best opportunity in healing
Treating wounds is reimbursable for:
Utilizing amniotic skin grafts for successful closure of non-healing chronic wounds.
Amniotic membranes are procured through voluntary donation from scheduled cesarean procedures of full-term, live births.
Amniotic tissue grafts are multi layers of amnion that offers the flexibility of placing either side toward the wound, adheres naturally to the patient’s tissue without sutures or other fixation, and is stored at room temperature with a 5-year shelf-life.
Dual layer amnion that offers the flexibility of placement
Easily controlled during application due to dual layer technology and 60 micron thickness
Adheres naturally to the patient’s tissue without the need for sutures or other fixation
Delivered and stored at room temperature with a 5-year shelf life
Requires no up front preparation or hydration
Provides orientation placement flexibility
Available in a variety of sizes to accommodate physician preferences
Minimally manipulated and processed using gentle detergents and water rinses
Terminally sterilized with electron beam which has shorter exposure times and produces less free radicals, resulting in less deterioration to tissue structures
Learn more about how to implement “Wound Care for Modern Times” into your practice. We’ll send you a link to a 20-minute video along with white papers and case studies. Complete turn-key “wound care in a box” program that you can implement and launch within one week, in most cases.
© Sanologics Inc. 2023